UBS Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-58,766
Closed -$16K 10414
2022
Q3
$16K Buy
58,766
+46,971
+398% +$12.8K ﹤0.01% 6669
2022
Q2
$9K Buy
+11,795
New +$9K ﹤0.01% 7207
2021
Q3
Sell
-1,671
Closed -$7K 9141
2021
Q2
$7K Sell
1,671
-8,495
-84% -$35.6K ﹤0.01% 7281
2021
Q1
$52K Buy
10,166
+4,842
+91% +$24.8K ﹤0.01% 5504
2020
Q4
$22K Buy
5,324
+5,282
+12,576% +$21.8K ﹤0.01% 5880
2020
Q3
$0 Sell
42
-7,405
-99% ﹤0.01% 7562
2020
Q2
$41K Buy
7,447
+5,206
+232% +$28.7K ﹤0.01% 5208
2020
Q1
$7K Buy
2,241
+1,767
+373% +$5.52K ﹤0.01% 6264
2019
Q4
$2K Sell
474
-3,625
-88% -$15.3K ﹤0.01% 6803
2019
Q3
$17K Sell
4,099
-13,161
-76% -$54.6K ﹤0.01% 5880
2019
Q2
$65K Sell
17,260
-2,840
-14% -$10.7K ﹤0.01% 4846
2019
Q1
$84K Sell
20,100
-1,775
-8% -$7.42K ﹤0.01% 4407
2018
Q4
$54K Buy
+21,875
New +$54K ﹤0.01% 5134
2018
Q3
Sell
-369
Closed -$1K 7259
2018
Q2
$1K Sell
369
-2,296
-86% -$6.22K ﹤0.01% 6930
2018
Q1
$10K Sell
2,665
-10,015
-79% -$37.6K ﹤0.01% 6007
2017
Q4
$46K Buy
+12,680
New +$46K ﹤0.01% 4956
2017
Q3
Sell
-31,703
Closed -$161K 6970
2017
Q2
$161K Buy
31,703
+30,871
+3,710% +$157K ﹤0.01% 4009
2017
Q1
$6K Sell
832
-1,521
-65% -$11K ﹤0.01% 6001
2016
Q4
$22K Buy
+2,353
New +$22K ﹤0.01% 5525
2016
Q3
Sell
-2,490
Closed -$35K 6920
2016
Q2
$35K Buy
+2,490
New +$35K ﹤0.01% 4953
2015
Q1
Sell
-1,449
Closed -$30K 6862
2014
Q4
$30K Buy
+1,449
New +$30K ﹤0.01% 5167